Cancer, Aids, and Hospice Article Archive CD from the International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

CANCER, AIDS, and HOSPICE CARE

Online access to Journal articles and formulations within one or more related compounding topics.

Full-color, full-text PDF files of articles and formulations from the Journal.
Print or save articles for your research, marketing, and educational needs.
Log-in to your account for keyword or topical search and download.
Purchased items appear with download icon in contents and search results.

Only $20000

(Select Format)

This archive contains the following articles listed by volume, issue and page number:

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
CANCER AND AIDS RELATED ARTICLES
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes de Wilde Sofieke, Crul Mirjam, Breukels Oscar	Mar/Apr 2023 Pg. 154-159
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Diazoxide 10-mg/mL in Oral Mix SF Allen Loyd V Jr	Nov/Dec 2022 Pg. 510
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 513
Calculations Stockton Shelly J	Jul/Aug 2022 Pg. 316
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez	Jan/Feb 2022 Pg. 6-8
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Growing a Compounding Practice: Successful Marketing to Underserved Populations McKettrick Greg, Yoch Doug	Jul/Aug 2021 Pg. 270-274
Moh's Paste, Modified Allen Loyd V Jr	Jul/Aug 2021 Pg. 326
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 234
Temozolomide 10 mg/mL in Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 235
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Hui Ada, Yin Jian, Liu Wei, Zheng Kai	May/Jun 2021 Pg. 246-257
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report McKettrick Greg, Yoch Doug	Mar/Apr 2021 Pg. 94-98
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Allen Loyd V Jr	Jan/Feb 2021 Pg. 31-38
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
Calculations Stockton Shelly J	Jan/Feb 2020 Pg. 52
Compatibility of Melphalan in Iodinated Contrast Media Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin	Jan/Feb 2020 Pg. 83-85
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Pope George, Daleo Charles, Batson SL	Sep/Oct 2019 Pg. 358-364
Sorafenib Capsules for Pediatric Use Allen Loyd V Jr	Sep/Oct 2019 Pg. 411
Methotrexate 2-mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2019 Pg. 235
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Allen Loyd V Jr	Jan/Feb 2019 Pg. 54
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Zur Eyal	Nov/Dec 2018 Pg. 446-454
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Nalenz Heiko, Köpf Ellen, Dietel Elke	Sep/Oct 2018 Pg. 417-423
Calculations Stockton Shelly J	Jul/Aug 2018 Pg. 314
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 318
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam	Jul/Aug 2018 Pg. 345-349
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Allen Loyd V Jr	May/Jun 2018 Pg. 237
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Allen Loyd V Jr	Mar/Apr 2018 Pg. 151
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Song Guiyun, Banov Daniel, Bassani August S	Jan/Feb 2018 Pg. 60-65
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Etoposide 20-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2017 Pg. 410
Tacrolimus 0.3-mg/mL Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2017 Pg. 416
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine	Jul/Aug 2017 Pg. 347-351
Azathioprine 10-mg/mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2017 Pg. 146
Calculations Stockton Shelly J	Jan/Feb 2017 Pg. 58-59
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 66-75
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 76-82
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 508
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 511
Calculations Stockton Shelly J	Sep/Oct 2016 Pg. 405
Tretinoin 10-mg Oral Capsules Allen Loyd V Jr	Jul/Aug 2016 Pg. 327
Carboplatin 50-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 226
Aprepitant 80-mg Capsules Allen Loyd V Jr	Jan/Feb 2016 Pg. 48
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa	Jan/Feb 2016 Pg. 81-85
Calculations Stockton Shelly J	Nov/Dec 2015 Pg. 502
Cytarabine 50-mg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 328
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Allen Loyd V	Jul/Aug 2015 Pg. 333
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Anderson Collin R, Halford Zachery, MacKay Mark	Jul/Aug 2015 Pg. 344-347
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin	May/Jun 2015 Pg. 261-267
Cisplatin 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 62
Daunorubicin 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 63
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica	Jan/Feb 2015 Pg. 73-77
Leucovorin 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2014 Pg. 497
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy	Nov/Dec 2014 Pg. 520-525
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino	Sep/Oct 2014 Pg. 358-364
Denileukin Diftitox 150-mcg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 328
Methotrexate 2.5-mg Capsules Allen Loyd V Jr	May/Jun 2014 Pg. 238
Tamoxifen 10-mg or 20-mg Capsules Allen Loyd V Jr	May/Jun 2014 Pg. 240
Fludarabine Phosphate 25-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 143
Secretin 4 mcg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 148
Lomustine 100-mg Capsules Allen Loyd V Jr	Jan/Feb 2014 Pg. 63
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Horace Alexis E, Akbarian-Tefagh Jessica	Nov/Dec 2013 Pg. 446-450
Metyrosine 250-mg Capsules Allen Loyd V Jr	Nov/Dec 2013 Pg. 506
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Horace Alexis E, Akbarian-Tefagh Jessica	Sep/Oct 2013 Pg. 388-391
Fluorouracil 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 417
Mesna 100-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 420
Methotrexate 25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 421
Dacarbazine 200-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 330
Mercaptopurine 75-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 234
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Williams LaVonn A	May/Jun 2013 Pg. 262-263
Dexrazoxane 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 149
Paclitaxel 6-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 151
Thiotepa 15-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 152
Granisetron 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 66
Octreotide 50-mcg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 72
Testosterone Cypionate 100-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 73
Calculations Stockton Shelly J, Saluja Hardeep Singh	Nov/Dec 2012 Pg. 498-499
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R	Sep/Oct 2012 Pg. 431-433
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Radojkovic Branko, Milic Jela, Calija Bojan	Sep/Oct 2012 Pg. 434-437
Ondansetron Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 339
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Zur Eyal	Mar/Apr 2012 Pg. 117-124
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Zhang Yang, Scarlett Cameron, Hutson Paul	Jan/Feb 2012 Pg. 82-85
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Zur Eyal	Jan/Feb 2012 Pg. 22-33
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Zur Eyal	Nov/Dec 2011 Pg. 458-463
Thioguanine 20-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2011 Pg. 506
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Kaiser Jeanette, Kramer Irene	Nov/Dec 2011 Pg. 515-520
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice	Sep/Oct 2011 Pg. 428-434
Methylprednisolone 4-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 340
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Allen Loyd V Jr	Sep/Oct 2010 Pg. 428
Potential Treatments for Radiation Dermatitis Corsini Lindsay	May/Jun 2010 Pg. 210-213
Cyclophosphamide 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 245
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 248
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Biundo Bruce	Mar/Apr 2010 Pg. 100-104
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules McElhiney Linda F	Mar/Apr 2010 Pg. 118-123
Mechlorethamine Hydrochloride 0.02% Topical Allen Loyd V Jr	Sep/Oct 2009 Pg. 434
Myristyl Nicotinate 5% Topical Gel Allen Loyd V Jr	Sep/Oct 2009 Pg. 435
Aprepitant 20-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2009 Pg. 153
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Allen Loyd V Jr	Mar/Apr 2009 Pg. 155
Ionic Hydration Solution for Anti-Cancer Therapy Allen Loyd V Jr	Mar/Apr 2009 Pg. 156
Compounding for Cancer in Companion Animals Mixon William, Northrup Nicole, Vail Jane	Jan/Feb 2009 Pg. 42-49
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A	Sep/Oct 2008 Pg. 460-462
Compounding Challenges for Immunocompromised Patients McElhiney Linda F	Nov/Dec 2008 Pg. 482-487
Tretinoin and Dexpanthenol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 361
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients Williams LaVonn A	Jan/Feb 2008 Pg. 16-27
Hospice and Compounding Pharmacy: Once Inseperable Williams LaVonn A	Jan/Feb 2008 Pg. 28-37
Calculations: Compounding for Cancer Patients Stockton Shelly J	Jan/Feb 2008 Pg. 62
Temozolomide 10-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2007 Pg. 336
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report McNulty Jack P	May/Jun 2007 Pg. 212-218
Busulfan 2-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 155
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 158
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 160
Principles of Pediatric Palliative Care and Pain Control Peralta Alexander Jr	Jan/Feb 2007 Pg. 10-15
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Jan/Feb 2007 Pg. 82-85
Cyclophosphamide 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 454
Dermatological Effects from Years in the Sun: Compounding Opportunities Jones Marty	Sep/Oct 2006 Pg. 336-342
Hydroxyurea 100 mg/mL Allen Loyd V Jr	Sep/Oct 2006 Pg. 384
Indinavir 10-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 385
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel Lawrence A, Zhang Yanping, Koontz Susannah E	Sep/Oct 2006 Pg. 396-399
Rifabutin 20-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 305
Granisetron 0.05-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 222
Mesna 20-mg/mL Syrup Allen Loyd V Jr	May/Jun 2006 Pg. 224
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A, Zhang Yanping	May/Jun 2006 Pg. 234-236
Chlorambucil 2-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 59
Efavirenz 20-mg/mL Oral Liquid, Anhydrous Allen Loyd V Jr	Jan/Feb 2006 Pg. 62
Mercaptopurine 50-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 64
Thioguanine 40-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 68
Dolasetron 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 475
Brompton's Mixture Allen Loyd V Jr	Jul/Aug 2005 Pg. 312
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Trissel Lawrence A, Zhang Yanping	Jul/Aug 2005 Pg. 320-322
Compounding Antiangiogenic Cancer Therapy for Animals Davidson Gigi S	May/Jun 2005 Pg. 195-198
Piroxicam 2-mg/mL Oral Liquid, Veterinary Allen Loyd V Jr	May/Jun 2005 Pg. 234
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 235-237
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Book and Literature Reviews Reed-Kane Dana, Foy Elizabeth, MacCara Mary E, MacLean Lindsay	Sep/Oct 2004 Pg. 324-327
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Allen Loyd V Jr	Sep/Oct 2004 Pg. 383
Book and Literature Reviews Reed-Kane Dana, Foy Elizabeth, MacCara Mary E	Jul/Aug 2004 Pg. 244-249
Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse Allen Loyd V Jr	Jul/Aug 2004 Pg. 296
Glycopyrrolate 0.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 218
Stomatitis Mouthwash Allen Loyd V Jr	Mar/Apr 2004 Pg. 140
Tacrolimus 0.5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 141
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Gupta Vishnu D	Sep/Oct 2003 Pg. 386-388
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Allen Loyd V Jr	May/Jun 2003 Pg. 183
The Hormonal Link to Breast Cancer: The Estrogen Matrix Zava David T	Jul/Aug 2002 Pg. 250-254
Sterilization of Talc for Use in Pleurodesis Fehr Richard, Henke Michelle, Ashworth Lisa D	Mar/Apr 2002 Pg. 140-141
Antineoplastic Agents Ashworth Lisa D	Jul/Aug 2001 Pg. 268-271
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou	Jul/Aug 2001 Pg. 320-322
Mitomycin 0.02% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2001 Pg. 209
Promethazine HCl 50-mg/mL in PLO Gel Allen Loyd V Jr	Jan/Feb 2001 Pg. 51
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Mathews Elizabeth	Sep/Oct 2000 Pg. 334
Hospice and the Role of the Compounding Pharmacist Carling Maureen A	Jul/Aug 2000 Pg. 246-249
Nausea and Vomiting in Hospice Patients Boomsma Diane	Jul/Aug 2000 Pg. 250-251
Ketamine for Pain in Hospice Patients Wood Robert M	Jul/Aug 2000 Pg. 253-254
Custom-Making Medications for the Hospice Patient Horwitz Robert	Jul/Aug 2000 Pg. 255-256
Surviving Cancer - How the Compounding Pharmacist Can Help Maddox Suzan	Jul/Aug 2000 Pg. 257-260
Providing Positive Outcomes through Compounding for Animal Cancer Patients Davidson Gigi S	Jul/Aug 2000 Pg. 264-272
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Allen Loyd V Jr	Jul/Aug 2000 Pg. 296
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Allen Loyd V Jr	Jul/Aug 2000 Pg. 297
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Allen Loyd V Jr	Jul/Aug 2000 Pg. 298
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Allen Loyd V Jr	Jul/Aug 2000 Pg. 302
Ondansetron HCl 8-mg/mL in PLO Allen Loyd V Jr	Jul/Aug 2000 Pg. 305
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Fuhrman L Clifton, Godwin Donald A, Davis R Alan	Jul/Aug 2000 Pg. 320-323
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Glasnapp Andrew	Sep/Oct 1999 Pg. 380-381
Tamoxifen Citrate Cream 0.1% Allen Loyd V Jr	Sep/Oct 1999 Pg. 381
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C	May/Jun 1999 Pg. 241-244
Oral Ulceration Mouthwash Allen Loyd V Jr	Jan/Feb 1999 Pg. 10
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Lieu Cynthia L, Chin Alfred, Gill Mark A	Jan/Feb 1999 Pg. 67-68
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Paoletti James E, Benavides Tomas J	Nov/Dec 1998 Pg. 414-415
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Xu Quanyun A, Trissel Lawrence A	Sep/Oct 1998 Pg. 382-384
Fluorouracil 5% Topical Stick Allen Loyd V Jr	Jul/Aug 1998 Pg. 300
Paclitaxel Compatibility with IV Express Filter Unit Xu Quanyun A, Trissel Lawrence A, Zhang Yanping	May/Jun 1998 Pg. 243-245
Estrogen and Breast Cancer: Is There a Link? Gever Marcy Portnoff	Jan/Feb 1998 Pg. 21-23
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Tenjarla Srini N, Ward Earl S, Fox Janet L	Jan/Feb 1998 Pg. 83-88
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Zhang Yanping, Trissel Lawrence A, Johansen Jamie F, Kimball Carol L	Jan/Feb 1998 Pg. 89-91
Compounding Pharmacists Play a Vital Role in AIDS Treatment Staton Tracy	Nov/Dec 1997 Pg. 386-388
Doxorubicin HCl-Vincristine Sulfate Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 324
Granisetron HCl-Dexamethasone Sodium Phosphate Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 326
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 328
Ondansetron HCl-Dexamethasone Sodium Phosphate Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 332
Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection Allen Loyd V Jr	Sep/Oct 1997 Pg. 333
Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations) Allen Loyd V Jr	Sep/Oct 1997 Pg. 334
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Gupta Vishnu D, Maswoswe J	Jul/Aug 1997 Pg. 282-283
Antiemetic Injection for Cancer Chemotherapy Allen Loyd V Jr	May/Jun 1997 Pg. 175
Rectal and Stomal Administration of Analgesic Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 12
Aromatherapy and the Hospice Patient Allen Loyd V Jr	Jan/Feb 1997 Pg. 18-19
ABH Hard Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 26
ABH Soft Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 27
ABH Sugar Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 27
Antiemetic Suppositories of the Gralla Type Allen Loyd V Jr	Jan/Feb 1997 Pg. 28
Metoclophen Nausea Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 31
Metoclophen-Modified Nausea Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 31
Ondansetron HCl Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 34-35
Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution Allen Loyd V Jr	Jan/Feb 1997 Pg. 37
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Allen Loyd V Jr	Jan/Feb 1997 Pg. 38
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Trissel Lawrence A, Xu Quanyun, Martinez Juan F	Jan/Feb 1997 Pg. 49-53

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
HOSPICE/PALLIATIVE CARE RELATED ARTICLES
Basics: Hollow-type Suppositories Allen Loyd V Jr	Jul/Aug 2022 Pg. 302-307
Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan	Jul/Aug 2021 Pg. 330-335
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 56
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice McNulty John P, Muller George	May/Jun 2014 Pg. 190-200
Palliative Care and Compounding for Household Pets Gaskins Jessica L	Nov/Dec 2012 Pg. 452-455
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian	Sep/Oct 2012 Pg. 364-368
When Traditional Medicine Fails Bash Robert	Jan/Feb 2010 Pg. 6-8
Compounding for Cancer in Companion Animals Mixon William, Northrup Nicole, Vail Jane	Jan/Feb 2009 Pg. 42-49
Topical Treatment of Neuropathic Pain Vadaurri Vince	May/Jun 2008 Pg. 182-190
Hospice and Compounding Pharmacy: Once Inseperable Williams LaVonn A	Jan/Feb 2008 Pg. 28-37
Principles of Pediatric Palliative Care and Pain Control Peralta Alexander Jr	Jan/Feb 2007 Pg. 10-15
Hospice Symptom Relief Kit: An Update Petrin Ronald L	Jul/Aug 2006 Pg. 288-290
Aseptic Compounding in New Zealand and the Use of Still Air Boxes Gargiulo Derryn, Kairuz Therese Eileen	Jul/Aug 2006 Pg. 293-295
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn	Mar/Apr 2006 Pg. 147-153
Hospice from a Compounding Pharmacist's Perspective Jones Marty	Mar/Apr 2006 Pg. 89-93
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Moon Richard B	Mar/Apr 2006 Pg. 95-98
The Story of Hospice Kuntz Rachael	Mar/Apr 2006 Pg. 100-102
The Dying Process Fonseca Simonne C	Mar/Apr 2006 Pg. 103-106
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 185
Indomethacin 50-mg Suppositories Allen Loyd V Jr	Sep/Oct 2003 Pg. 375
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Allen Loyd V Jr	May/Jun 2003 Pg. 183
Hospice and the Role of the Compounding Pharmacist Carling Maureen A	Jul/Aug 2000 Pg. 246-249
Nausea and Vomiting in Hospice Patients Boomsma Diane	Jul/Aug 2000 Pg. 250-251
Ketamine for Pain in Hospice Patients Wood Robert M	Jul/Aug 2000 Pg. 253-254
Custom-Making Medications for the Hospice Patient Horwitz Robert	Jul/Aug 2000 Pg. 255-256
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Allen Loyd V Jr	Jul/Aug 2000 Pg. 289-293
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Allen Loyd V Jr	Jul/Aug 2000 Pg. 297
Managing Pain in the Terminally Ill Williams Clifford L	Mar/Apr 1998 Pg. 111-114
The Symptom Relief Kit for Hospice Patients Petrin Ronald L	Mar/Apr 1998 Pg. 116-117
Compounding Pharmacists Play a Vital Role in AIDS Treatment Staton Tracy	Nov/Dec 1997 Pg. 386-388
Hospice Care and the Pharmacist Allen Loyd V Jr	Jan/Feb 1997 Pg. 10-12
Rectal and Stomal Administration of Analgesic Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 12
Aromatherapy and the Hospice Patient Allen Loyd V Jr	Jan/Feb 1997 Pg. 18-19
Aromatherapy Mood Elevation No. 1 Allen Loyd V Jr	Jan/Feb 1997 Pg. 20
Aromatherapy Mood Elevation No. 2 Allen Loyd V Jr	Jan/Feb 1997 Pg. 21
ABH Hard Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 26
ABH Soft Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 27
ABH Sugar Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 27
Morphine Sulfate Slow-Release Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 32-33
Ondansetron HCl Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 34-35
Morphine Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 36

	Instant Online Access